GOLDMAN SACHS GROUP INC - C B PHARMA ACQUISITION CORP ownership

C B PHARMA ACQUISITION CORP's ticker is CNLMU and the CUSIP is G2029P100. A total of 7 filers reported holding C B PHARMA ACQUISITION CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of C B PHARMA ACQUISITION CORP
ValueSharesWeighting
Q1 2016$176,000
-0.6%
17,3000.0%0.00%
Q4 2015$177,000
-2.7%
17,300
-1.1%
0.00%
Q3 2015$182,000
-0.5%
17,5000.0%0.00%
Q2 2015$183,000
-7.6%
17,500
-9.8%
0.00%
Q1 2015$198,000
-1.5%
19,400
-3.0%
0.00%
Q4 2014$201,00020,0000.00%
Other shareholders

There were no reported owners of C B PHARMA ACQUISITION CORP in Q3 2015.

NameSharesValueWeighting ↓
View complete list of C B PHARMA ACQUISITION CORP shareholders